Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma

Published:2020-02 Issue: Volume:126 Page:1-10
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Donskov Frede,Motzer Robert J.,Voog Eric,Hovey Elizabeth,Grüllich Carsten,Nott Louise M.,Cuff Katharine,Gil Thierry,Jensen Niels Viggo,Chevreau Christine,Negrier Sylvie,Depenbusch Reinhard,Bergmann Lothar^ORCID,Cornelio Izzy,Champsaur Anne,Escudier Bernard,Pal Sumanta^ORCID,Powles Thomas,Choueiri Toni K.

Funder

Exelixis

Pfizer

Novartis

Ipsen

Health Research Foundation of Central Denmark Region

Bristol-Myers Squibb

Genentech

Roche

Eisai

Amgen

Eusa Pharma

Eusa

Astellas Pharma

Medivation

AstraZeneca

MedImmune

Bayer

BMS

Cerulean

Foundation Medicine Inc

Tracon

Roche Products Limited

GlaxoSmithKline

Merck

Peloton

Prometheus Laboratories

Corvus

Calithera

Analysis Group and Takeda

Alexion

Sanofi

Aventis

EMD Serono

UpToDate

NCCN

Analysis Group

Michael J. Hennessy (MJH) Associates

PA

USA

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. International variations and trends in renal cell carcinoma incidence and mortality;Znaor;Eur Urol,2015

2. Anticipating the "silver tsunami": prevalence trajectories and comorbidity burden among older cancer survivors in the United States;Bluethmann;Cancer Epidemiol Biomark Prev,2016

3. Elderly patients with metastatic renal cell carcinoma: position paper from the International Society of Geriatric Oncology;Kanesvaran;Lancet Oncol,2018

4. Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis;Scoll;J Urol,2009

5. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma;Verhoest;Eur Urol,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcomatoid Renal Clear Cell Carcinoma with Brain Metastasis: A Case Report and Literature Review;British Journal of Hospital Medicine;2024-08-30

2. Targeted therapy of RET fusion-positive non-small cell lung cancer;Frontiers in Oncology;2022-12-13

3. An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives;Therapeutics and Clinical Risk Management;2022-06

4. Sex and Gender Differences in Anticancer Treatment Toxicity: A Call for Revisiting Drug Dosing in Oncology;Endocrinology;2022-05-02

5. Translational Strategies to Target Metastatic Bone Disease;Cells;2022-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3